BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 32817520)

  • 21. Stemazole Promotes Oligodendrocyte Precursor Cell Survival In Vitro and Remyelination In Vivo.
    Zhu Y; Chen M; Zhang Y; Han M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CZ-7, a new derivative of Claulansine F, promotes remyelination induced by cuprizone by enhancing myelin debris clearance.
    Wang SS; Bi HZ; Chu SF; Dong YX; He WB; Tian YJ; Zang YD; Zhang DM; Zhang Z; Chen NH
    Brain Res Bull; 2020 Jun; 159():67-78. PubMed ID: 32289743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A targeted extracellular vesicles loaded with montelukast in the treatment of demyelinating diseases.
    Xiao Y; Zhang Y; Gao YH; Zhao ZH; He J; Gao R; Guo YX; Wang LB; Li X
    Biochem Biophys Res Commun; 2022 Feb; 594():31-37. PubMed ID: 35066377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.
    Liu L; Darnall L; Hu T; Choi K; Lane TE; Ransohoff RM
    J Neurosci; 2010 Jul; 30(27):9074-83. PubMed ID: 20610741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.
    Butti E; Bacigaluppi M; Chaabane L; Ruffini F; Brambilla E; Berera G; Montonati C; Quattrini A; Martino G
    J Neurosci; 2019 Jul; 39(28):5481-5492. PubMed ID: 31138656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin therapy inhibits remyelination in the central nervous system.
    Miron VE; Zehntner SP; Kuhlmann T; Ludwin SK; Owens T; Kennedy TE; Bedell BJ; Antel JP
    Am J Pathol; 2009 May; 174(5):1880-90. PubMed ID: 19349355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.
    Selvaraju R; Bernasconi L; Losberger C; Graber P; Kadi L; Avellana-Adalid V; Picard-Riera N; Baron Van Evercooren A; Cirillo R; Kosco-Vilbois M; Feger G; Papoian R; Boschert U
    Mol Cell Neurosci; 2004 Apr; 25(4):707-21. PubMed ID: 15080898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PARP1-mediated PARylation activity is essential for oligodendroglial differentiation and CNS myelination.
    Wang Y; Zhang Y; Zhang S; Kim B; Hull VL; Xu J; Prabhu P; Gregory M; Martinez-Cerdeno V; Zhan X; Deng W; Guo F
    Cell Rep; 2021 Oct; 37(1):109695. PubMed ID: 34610310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of oligodendroglial Stat3 is required for efficient remyelination.
    Steelman AJ; Zhou Y; Koito H; Kim S; Payne HR; Lu QR; Li J
    Neurobiol Dis; 2016 Jul; 91():336-46. PubMed ID: 27060559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Butyrate suppresses demyelination and enhances remyelination.
    Chen T; Noto D; Hoshino Y; Mizuno M; Miyake S
    J Neuroinflammation; 2019 Aug; 16(1):165. PubMed ID: 31399117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendrosomal nanocurcumin promotes remyelination through induction of oligodendrogenesis in experimental demyelination animal model.
    Motavaf M; Sadeghizadeh M; Babashah S; Zare L; Javan M
    J Tissue Eng Regen Med; 2020 Oct; 14(10):1449-1464. PubMed ID: 32750189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic CCN3 expression in the murine CNS does not confer essential roles in myelination or remyelination.
    de la Vega Gallardo N; Penalva R; Dittmer M; Naughton M; Falconer J; Moffat J; de la Fuente AG; Hombrebueno JR; Lin Z; Perbal B; Ingram RJ; Evergren E; Fitzgerald DC
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):18018-18028. PubMed ID: 32651278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unconventional Myosin ID is Involved in Remyelination After Cuprizone-Induced Demyelination.
    Yamazaki R; Baba H; Yamaguchi Y
    Neurochem Res; 2018 Jan; 43(1):195-204. PubMed ID: 28986688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vivo Optical Imaging of Myelination Events in a Myelin Basic Protein Promoter-Driven Luciferase Transgenic Mouse Model.
    Cao J; Hu Y; Shazeeb MS; Pedraza CE; Pande N; Weinstock D; Polites GH; Zhang W; Chandross KJ; Ying X
    ASN Neuro; 2018; 10():1759091418777329. PubMed ID: 29806482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin C promotes oligodendrocytes generation and remyelination.
    Guo YE; Suo N; Cui X; Yuan Q; Xie X
    Glia; 2018 Jul; 66(7):1302-1316. PubMed ID: 29423921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis.
    Marro BS; Skinner DD; Cheng Y; Grist JJ; Dickey LL; Eckman E; Stone C; Liu L; Ransohoff RM; Lane TE
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting of KOR by famotidine promotes OPC maturation differentiation and CNS remyelination via STAT3 signaling pathway.
    Bao MY; Feng CY; Li XQ; He Y; Han B; Yang YN; Zhang Y; Li X
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):131964. PubMed ID: 38692525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginsenoside Rg1 promotes remyelination and functional recovery in demyelinating disease by enhancing oligodendrocyte precursor cells-mediated myelin repair.
    Liu L; Du X; Yang Q; Li M; Ran Q; Liu Q; Yang L; Sun L; Guo Y; Li Y; Chen Y; Zhu X; Li Q
    Phytomedicine; 2022 Nov; 106():154309. PubMed ID: 35994846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination.
    Coppolino GT; Marangon D; Negri C; Menichetti G; Fumagalli M; Gelosa P; Dimou L; Furlan R; Lecca D; Abbracchio MP
    Glia; 2018 May; 66(5):1118-1130. PubMed ID: 29424466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelination.
    Maheshwari A; Janssens K; Bogie J; Van Den Haute C; Struys T; Lambrichts I; Baekelandt V; Stinissen P; Hendriks JJ; Slaets H; Hellings N
    Mediators Inflamm; 2013; 2013():685317. PubMed ID: 23818742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.